# Loop Diuretics

## Examples

- `furosemide`
- `bumetanide`
- `torsemide`
- `ethacrynic acid` _(non-sulfonamide derivative — used if sulfa allergy)_

## Mechanism of Action (MOA)

- Act on the **thick ascending limb of the loop of Henle (TAL)**.
- **Inhibit Na⁺/K⁺/2Cl⁻ cotransporter (NKCC2)** on the luminal membrane.
- This:
  - ↓ Na⁺, K⁺, and Cl⁻ reabsorption → strong natriuresis and diuresis.
  - Abolishes medullary osmotic gradient → prevents water reabsorption from the collecting duct.
  - ↑ Ca²⁺ and Mg²⁺ excretion (opposite to thiazides).

![Loop Acting](/pharmacology/cvs/anti-hypertensives/diuretics/loop-diuretics-acting.png)

## Pharmacodynamics (Effects)

- **Powerful diuretics** — can excrete up to 20% of filtered Na⁺.
- Rapid and short-acting; effective even in renal impairment.
- **↓ Blood volume → ↓ cardiac output → ↓ BP.**
- Also cause **venodilation** (especially `furosemide`) → ↓ preload (useful in acute pulmonary edema).

## Pharmacokinetics

| Property             | Notes                                                                                   |
| :------------------- | :-------------------------------------------------------------------------------------- |
| **Route**            | Oral and IV (IV for emergencies).                                                       |
| **Onset / Duration** | Oral: onset 30–60 min; duration 4–6 h. IV: onset 5 min; duration 2–3 h.                 |
| **Protein binding**  | Highly protein-bound.                                                                   |
| **Elimination**      | Secreted into proximal tubule by organic acid transporter; excreted unchanged in urine. |
| **Renal failure**    | Still effective (unlike thiazides).                                                     |

## Indications

- **Acute pulmonary edema** (first-line, rapid relief).
- **Congestive heart failure (CHF)** with fluid overload.
- **Hypertension** — when associated with renal impairment or resistant cases.
- **Acute renal failure** — to promote urine flow (convert oliguric to non-oliguric).
- **Hypercalcemia** — promotes Ca²⁺ excretion (with IV saline).
- **Cirrhotic or nephrotic edema**.

## Adverse Effects

Mnemonic: **“OH DANG!”**

| Effect                            | Mechanism                                                     |
| :-------------------------------- | :------------------------------------------------------------ |
| **Ototoxicity**                   | Dose-related, esp. with `ethacrynic acid` or aminoglycosides. |
| **Hypokalemia**                   | ↑ Na⁺ delivery to distal tubule → ↑ K⁺ loss.                  |
| **Hypocalcemia & Hypomagnesemia** | ↓ reabsorption of divalent cations.                           |
| **Dehydration & Hypovolemia**     | Excessive water loss.                                         |
| **Allergy (sulfa-based)**         | Rash, photosensitivity (except `ethacrynic acid`).            |
| **Nephritis (interstitial)**      | Rare.                                                         |
| **Gout (hyperuricemia)**          | Competes with uric acid for excretion.                        |
| **Metabolic alkalosis**           | From ↑ H⁺ loss with K⁺.                                       |

## Cautions

- **Elderly** — risk of dehydration, electrolyte imbalance.
- **Hypotension / volume depletion.**
- **Diabetics** — mild hyperglycemia possible.
- **Concurrent ototoxic drugs** — e.g. aminoglycosides, cisplatin.
- **On digoxin** — hypokalemia ↑ risk of arrhythmia.

## Contraindications

- **Severe hyponatremia / hypokalemia / dehydration.**
- **Hypersensitivity to sulfonamides** (use `ethacrynic acid` instead).
- **Hepatic coma** — may worsen encephalopathy due to alkalosis.
